58
FDA regulatory actions, the FDA has urged the wireless
phone industry to take a number of steps, including the
following:
• Support needed research into possible biological
effects of RF of the type emitted by wireless phones;
• Design wireless phones in a way that minimizes any RF
exposure to the user that is not necessary for device
function; and
• Cooperate in providing users of wireless phones with
the best possible information on possible effects of
wireless phone use on human health.
The FDA belongs to an interagency working group of
the federal agencies that have responsibility for different
aspects of RF safety to ensure coordinated efforts at
the federal level. The following agencies belong to this
working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency
• Occupational Safety and Health Administration
• National Telecommunications and Information
Administration
The National Institutes of Health participates in some
interagency working group activities, as well.
The FDA shares regulatory responsibilities for wireless
phones with the Federal Communications Commission
(FCC). All phones that are sold in the United States must
comply with FCC safety guidelines that limit RF exposure.
The FCC relies on the FDA and other health agencies for
safety questions about wireless phones.